SUBSCRIBE
SUBSCRIBE
News   Deals

Merck & Co., Inc. (JOBS) Inks Domestic Rights to Afluria from CSL Limited

September 29, 2009 | 
1 min read
Bookmark and Share

Bizjournals.com -- Merck & Co. Inc. entered into a deal Monday for the U.S. rights to Afluria, a seasonal influenza vaccine manufactured by CSL Ltd. of Australia.
Mergers & acquisitions
Merck & Co.
MORE ON THIS TOPIC
Global communication network concept. Worldwide business. Human resources.
Drug Development
CRO Boom in APAC region, With China at the Forefront
November 19, 2025
 · 
5 min read
 · 
Jennifer Smith-Parker
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Mergers & acquisitions
UPDATE: Avadel Accepts Alkermes’ Revised $2.37B Counteroffer, Besting Lundbeck
November 19, 2025
 · 
3 min read
 · 
Tristan Manalac
Podcast
Billions More in M&A, Another Bidding War and More FDA Drama
November 19, 2025
 · 
1 min read
 · 
Heather McKenzie
Johnson and Johnson sign
Mergers & acquisitions
J&J, Aiming for $50B in Cancer Sales, Buys Halda for $3B in Cash
November 17, 2025
 · 
2 min read
 · 
Dan Samorodnitsky